Showing results (1251-1260 of 1,334) with videos related to
Sort By:
Pageof 134
Blood|October 17, 2025
Diagnosis and Management of AML in Pediatric Patients: Consensus Recommendations from an International Expert PanelC Michel Zwaan, Sarah K Tasian, Richard Aplenc, et al.Haematologica|July 28, 2011
Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemiaBrian V Balgobind, Iris H I M Hollink, Susan T C J M Arentsen-Peters, et al.Pediatric Blood & Cancer|February 4, 2010
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conferenceTerzah M Horton, Richard Sposto, Patrick Brown, et al.Leukemia|August 26, 2024
A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemiaJoost B Koedijk, Inge van der Werf, Livius Penter, et al.Hemasphere|November 3, 2025
Isatuximab in combination with chemotherapy for pediatric patients with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia: The ISAKIDS studyAndré Baruchel, Karsten Nysom, Hyoung Jin Kang, et al.Plos One|January 16, 2013
Engagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cellsMahban Irandoust, Julian Alvarez Zarate, Isabelle Hubeek, et al.Blood|February 14, 2014
Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesisJulia Skokowa, Doris Steinemann, Jenny E Katsman-Kuipers, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid LeukemiaC Michel Zwaan, Edward A Kolb, Dirk Reinhardt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2024
Menin Inhibition With Revumenib for <i>KMT2A</i>-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)Ghayas C Issa, Ibrahim Aldoss, Michael J Thirman, et al.JCO Precision Oncology|June 26, 2023
Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORMAnna-Elisa Heipertz, Kristian W Pajtler, Elke Pfaff, et al.Pageof 134